Issue 13/2017
Content (9 Articles)
Nerve Growth Factor Antagonists: Is the Future of Monoclonal Antibodies Becoming Clearer?
- Current Opinion
Bernard Bannwarth, Marie Kostine
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook
- Leading Article
Jusleen Ahluwalia, Jeremy Udkoff, Andrea Waldman, Jenna Borok, Lawrence F. Eichenfield
Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects
- Therapy in Practice
Garyphallia Poulakou, Dimitrios K. Matthaiou, David P. Nicolau, Georgios Siakallis, George Dimopoulos
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity
- Review Article
Andrea Santamato, Francesco Panza
Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review
- Review Article
Selene R. T. Veerman, Peter F. J. Schulte, Lieuwe de Haan
Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases
- Open Access
- Original Research Article
Y. Schuller, C. E. M. Hollak, C. C. Gispen-de Wied, V. Stoyanova-Beninska, M. Biegstraaten
Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT
- Adis Drug Evaluation
Yahiya Y. Syed